The American Academy of Pediatrics hypertension guidelines identify obese youth at high cardiovascular risk among individuals non-hypertensive by the European Society of Hypertension guidelines.


Journal

European journal of preventive cardiology
ISSN: 2047-4881
Titre abrégé: Eur J Prev Cardiol
Pays: England
ID NLM: 101564430

Informations de publication

Date de publication:
01 2020
Historique:
pubmed: 8 8 2019
medline: 22 12 2020
entrez: 8 8 2019
Statut: ppublish

Résumé

Two different systems for the screening and diagnosis of hypertension (HTN) in children currently coexist, namely, the guidelines of the 2017 American Academy of Pediatrics (AAP) and the 2016 European Society for Hypertension (ESH). The two systems differ in the lowered cut-offs proposed by the AAP versus ESH. We evaluated whether the reclassification of hypertension by the AAP guidelines in young people who were defined non-hypertensive by the ESH criteria would classify differently overweight/obese youth in relation to their cardiovascular risk profile. A sample of 2929 overweight/obese young people (6-16 years) defined non-hypertensive by ESH (ESH Using the AAP criteria, 327/2929 (11%) young people were categorized as hypertensive (ESH The reclassification of hypertension by the AAP guidelines in young people overweight/obese defined non-hypertensive by the ESH criteria identified a significant number of individuals with high blood pressure and abnormal cardiovascular risk. Our data support the need of a revision of the ESH criteria.

Sections du résumé

BACKGROUND
Two different systems for the screening and diagnosis of hypertension (HTN) in children currently coexist, namely, the guidelines of the 2017 American Academy of Pediatrics (AAP) and the 2016 European Society for Hypertension (ESH). The two systems differ in the lowered cut-offs proposed by the AAP versus ESH.
OBJECTIVES
We evaluated whether the reclassification of hypertension by the AAP guidelines in young people who were defined non-hypertensive by the ESH criteria would classify differently overweight/obese youth in relation to their cardiovascular risk profile.
METHODS
A sample of 2929 overweight/obese young people (6-16 years) defined non-hypertensive by ESH (ESH
RESULTS
Using the AAP criteria, 327/2929 (11%) young people were categorized as hypertensive (ESH
CONCLUSIONS
The reclassification of hypertension by the AAP guidelines in young people overweight/obese defined non-hypertensive by the ESH criteria identified a significant number of individuals with high blood pressure and abnormal cardiovascular risk. Our data support the need of a revision of the ESH criteria.

Identifiants

pubmed: 31387383
doi: 10.1177/2047487319868326
doi:

Types de publication

Comparative Study Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

8-15

Commentaires et corrections

Type : CommentIn

Auteurs

Procolo Di Bonito (PD)

Department of Internal Medicine, 'S. Maria delle Grazie', Pozzuoli Hospital, Naples, Italy.

Maria Rosaria Licenziati (MR)

Department of Paediatrics, AORN Santobono-Pausilipon, Naples, Italy.

Marco G Baroni (MG)

Department of Experimental Medicine, Sapienza University of Rome, Italy.

Claudio Maffeis (C)

Paediatric Diabetes and Metabolic Disorders Unit, University of Verona, Italy.

Anita Morandi (A)

Paediatric Diabetes and Metabolic Disorders Unit, University of Verona, Italy.

Melania Manco (M)

IRCCS Bambino Gesù Children's Hospital, Rome, Italy.

Emanuele Miraglia Del Giudice (E)

Department of Woman, Child and General and Specialized Surgery, University of Campania 'Luigi Vanvitelli', Naples, Italy.

Anna Di Sessa (AD)

Department of Woman, Child and General and Specialized Surgery, University of Campania 'Luigi Vanvitelli', Naples, Italy.

Giuseppina Campana (G)

Department of Paediatrics, AORN Santobono-Pausilipon, Naples, Italy.

Nicola Moio (N)

Department of Cardiology, 'S. Maria delle Grazie', Pozzuoli, Naples, Italy.

Luisa Gilardini (L)

IRCCS Istituto Auxologico Italiano, Department of Medical Sciences and Rehabilitation, Milan, Italy.

Claudio Chiesa (C)

Institute of Translational Pharmacology, National Research Council, Rome, Italy.

Lucia Pacifico (L)

Policlinico Umberto I Hospital, Sapienza University of Rome, Italy.

Giovanni de Simone (G)

Hypertension Research Centre and Department of Advanced Biomedical Sciences, Federico II University Hospital, Naples, Italy.

Giuliana Valerio (G)

Department of Movement and Wellbeing Sciences, University of Naples Parthenope, Naples, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH